SUZHOU and SHANGHAI, China, April 30, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that it will participate in the following upcoming virtual conferences:

See the original post:
Gracell Biotechnologies to Participate in Upcoming Virtual Conferences in May

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh